4.7 Article

Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma

Athenais Grave et al.

Summary: This study examined the safety and efficacy of pelvic chemoradiation (CRT) in patients with metastatic squamous cell carcinoma of the anus (SCCA) who achieved objective response after initial treatment with systemic docetaxel, cisplatin, and 5-Fluorouracil (DCF). The results showed that despite some toxicities and low compliance with chemotherapy, local CRT was feasible and effective in providing high local control rates in these patients.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale

Gary M. Clifford et al.

Summary: Certain population groups such as PLHIV, MSM, SOTRs, and patients with autoimmune diseases have higher anal cancer risks. The incidence rates vary significantly among different groups, with HIV-positive MSM showing the highest rates. Prioritizing anal cancer prevention and research in these high-risk groups is crucial.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Molecular characterization of squamous cell carcinoma of the anal canal

Samantha A. Armstrong et al.

Summary: The differences in molecular profiling between TP53-MT and TP53-WT SCCA suggest different carcinogenic pathways that may affect treatment response, while low-frequency mutations in several druggable genes could offer therapeutic opportunities for patients with SCCA.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Article Oncology

A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma

Soledad Iseas et al.

Summary: This study analyzed viral, immune, and mutational characteristics in non-metastatic anal squamous cell carcinoma patients, revealing a high prevalence of HPV-16 infection and mutations affecting cancer driver genes. PD-L1 expression was significantly associated with disease-free survival and overall survival in these patients, showcasing its potential for stratifying responders to treatment.

TRANSLATIONAL ONCOLOGY (2021)

Article Immunology

Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies

Feixue Wei et al.

Summary: The study evaluated the age-specific prevalence of anal HPV and HSIL in men, stratified by HIV status and sexuality, highlighting the importance of gender-neutral HPV vaccination and anal cancer screening research for high-risk populations.

LANCET HIV (2021)

Review Oncology

Present and Future Research on Anal Squamous Cell Carcinoma

Laurie Spehner et al.

Summary: Recent advancements in research networks and understanding of tumor biology in SCCA have led to significant breakthroughs in clinical research for squamous cell carcinoma of the anus. The arrival of taxane-based chemotherapy, immunotherapy, and new biomarkers like HPV ctDNA in liquid biopsy have reshaped the present and future of treatment strategies for this disease.

CANCERS (2021)

Article Oncology

A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes

Camila Motta Venchiarutti Moniz et al.

Summary: The study revealed that initial response to chemoradiation therapy is primarily influenced by clinical staging and HIV status. The absence of complete remission was associated with poorer 5-year overall survival.

JOURNAL OF CANCER (2021)

Article Oncology

Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015

Ashish A. Deshmukh et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

Article Oncology

Patterns of recurrence in anal cancer: a detailed analysis

Martin P. Nilsson et al.

RADIATION ONCOLOGY (2020)

Article Multidisciplinary Sciences

Anal cancer in high-income countries: Increasing burden of disease

Yoon-Jung Kang et al.

PLOS ONE (2018)

Article Oncology

Worldwide burden of cancer attributable to HPV by site, country and HPV type

Catherine de Martel et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Article Oncology

Epidemiology of Anal Canal Cancer

Valerie M. Nelson et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)

Article Surgery

HIV positivity and anal cancer outcomes: A single-center experience

Nicole Wieghard et al.

AMERICAN JOURNAL OF SURGERY (2016)

Article Gastroenterology & Hepatology

Anal squamous cell carcinoma: An evolution in disease and management

Marc C. Osborne et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Oncology

Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer

Peter P. Grimminger et al.

CLINICAL CANCER RESEARCH (2011)